Your region is set to . If this is incorrect, please change your region.

Life Sciences

In the rapidly evolving life sciences sector, you need a trusted legal partner to deliver practical, cost-effective legal advice and to support you at every stage — whether you’re a startup or a multinational company.

With over 150 professionals in the Gowling WLG Life Sciences Group across Canada and around the world, we have the technical expertise to understand the unique challenges you face throughout your life cycle.

Full-service support

Our professionals work with your business, human resource and regulatory teams to provide guidance and support in key areas of life sciences — from clinical trial protocols, the drafting of clinical trial agreements and drug submissions to licensing, financing, employment and labour issues, R&D, pricing, reimbursement, and more.

Doing the deal

Whether structuring transactions to mitigate risk and achieve tax and cost efficiencies, licensing products, or going through a merger and acquisition, we help life sciences companies — including investors, underwriters, public issuers, innovative startups and global brands — realize their business objectives.

Securing exclusivity

In addition to patent drafting and global filing, prosecution and enforcement, we’ll advise on your eligibility requirements for listing on the Canadian PM(NOC) Patent Register to ensure your product is fairly priced. In Canada, we take into account the value of patent protection in light of other factors, including data protection/exclusivity and the Patented Medicine Prices Review Board (PMPRB).

Top-tier expertise

Our intellectual property litigators have been shaping IP law for decades, appearing in more patent actions and PM(NOC) proceedings in the Federal Court of Canada than any other law firm. We help you maximize the value of your IP.

Enforcing your rights

Our experienced competition law, regulatory, class actions and product liability teams are on hand to help you mitigate risk and, if required, litigate conflicts that arise.


We help ensure your product launch activities comply with applicable laws and professional and industry codes of conduct, including those in advertising and health care.

Learn more

To learn more about how we can help you succeed, please contact John Norman or any member of our team.

Key Contact

John Norman, PhD
John Norman, PhD

Meet our Life Sciences professionals

View all

Life Sciences Client Work

Related Insights & Resources

Canada-EU Comprehensive Economic and Trade Agreement (CETA) approved by European Parliament

Richard G. Dearden, Wendy J. Wagner

Articles February 16, 2017

Canadian patent law: 2016 year in review

Alex Gloor, Michael Crichton

Articles January 4, 2017

Challenge to patentee’s right to elect between damages and accounting of profits rejected

Alex Gloor

Articles November 10, 2016

Changes to IP rights on the horizon: Canada introduces legislation to implement CETA

Multiple Authors

Articles November 4, 2016

Federal Court of Appeal grants minister of health the right to be wrong

Multiple Authors

Articles October 24, 2016

Patent survives anticipation attack based on use in phase III clinical trial

Kiernan A. Murphy, Marc Crandall

Articles September 22, 2016

Subscribe to our updates